Horsting MWB, Franken MD, Meulenbelt J, van Klei WA, de Lange DW. The etiology and outcome of non-traumatic coma in critical care: a systematic review. BMC Anesthesiol. 2015;15:65. https://doi.org/10.1186/s12871-015-0041-9.
Edlow JA, Rabinstein A, Traub SJ, Wijdicks EFM. Diagnosis of reversible causes of coma. Lancet. 2014;384:2064–76. https://doi.org/10.1016/S0140-6736(13)62184-4.
Lutz M, Möckel M, Lindner T, Ploner CJ, Braun M, Schmidt WU. The accuracy of initial diagnoses in coma: an observational study in 835 patients with non-traumatic disorder of consciousness. Scand J Trauma Resusc Emerg Med. 2021;29:15. https://doi.org/10.1186/s13049-020-00822-w.
Article PubMed PubMed Central Google Scholar
van Rein EAJ, van der Sluijs R, Houwert RM, Gunning AC, Lichtveld RA, Leenen LPH, van Heijl M. Effectiveness of prehospital trauma triage systems in selecting severely injured patients: Is comparative analysis possible? Am J Emerg Med. 2018;36:1060–9. https://doi.org/10.1016/j.ajem.2018.01.055.
Sadaf H, Desai VR, Misra V, Golanov E, Hegde ML, Villapol S, et al. A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage. Ann Clin Transl Neurol. 2021;8:2211–21. https://doi.org/10.1002/acn3.51443.
Article PubMed PubMed Central Google Scholar
Foerch C, Niessner M, Back T, Bauerle M, de Marchis GM, Ferbert A, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem. 2012;58:237–45. https://doi.org/10.1373/clinchem.2011.172676.
Article CAS PubMed Google Scholar
Katsanos AH, Makris K, Stefani D, Koniari K, Gialouri E, Lelekis M, et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke. 2017;48:2586–8. https://doi.org/10.1161/STROKEAHA.117.018409.
Article CAS PubMed Google Scholar
Luger S, Jæger HS, Dixon J, Bohmann FO, Schaefer J, Richieri SP, et al. Diagnostic accuracy of glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 serum concentrations for differentiating acute intracerebral hemorrhage from ischemic stroke. Neurocrit Care. 2020;33:39–48. https://doi.org/10.1007/s12028-020-00931-5.
Article CAS PubMed Google Scholar
Kalra L-P, Khatter H, Ramanathan S, Sapehia S, Devi K, Kaliyaperumal A, et al. Serum GFAP for stroke diagnosis in regions with limited access to brain imaging (BE FAST India). Eur Stroke J. 2021;6:176–84. https://doi.org/10.1177/23969873211010069.
Article PubMed PubMed Central Google Scholar
Luger S, Witsch J, Dietz A, Hamann GF, Minnerup J, Schneider H, et al. Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin Chem. 2017;63:377–85. https://doi.org/10.1373/clinchem.2016.263335.
Article CAS PubMed Google Scholar
Anderson TN, Hwang J, Munar M, Papa L, Hinson HE, Vaughan A, Rowell SE. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury. J Trauma Acute Care Surg. 2020;89:80–6. https://doi.org/10.1097/TA.0000000000002706.
Article CAS PubMed Google Scholar
Lei J, Gao G, Feng J, Jin Y, Wang C, Mao Q, Jiang J. Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study. Crit Care. 2015. https://doi.org/10.1186/s13054-015-1081-8.
Biberthaler P, Musaelyan K, Krieg S, Meyer B, Stimmer H, Zapf J, et al. Evaluation of acute glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 plasma levels in traumatic brain injury patients with and without intracranial lesions. Neurotrauma Rep. 2021;2:617–25. https://doi.org/10.1089/neur.2021.0048.
Oris C, Bouillon-Minois J-B, Kahouadji S, Pereira B, Dhaiby G, Defrance VB, et al. S100B vs. “GFAP and UCH-L1” assays in the management of mTBI patients. Clin Chem Lab Med. 2023. https://doi.org/10.1515/cclm-2023-1238.
Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6: e012799. https://doi.org/10.1136/bmjopen-2016-012799.
Tichy J, Spechtmeyer S, Mittelbronn M, Hattingen E, Rieger J, Senft C, Foerch C. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma. J Neurooncol. 2016;126:361–9. https://doi.org/10.1007/s11060-015-1978-8.
Article CAS PubMed Google Scholar
van Asperen JV, Fedorushkova DM, Robe PAJT, Hol EM. Investigation of glial fibrillary acidic protein (GFAP) in body fluids as a potential biomarker for glioma: a systematic review and meta-analysis. Biomarkers. 2022;27:1–12. https://doi.org/10.1080/1354750X.2021.2006313.
Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019;73:3018–26. https://doi.org/10.1016/j.jacc.2019.03.507.
Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14–31. https://doi.org/10.2337/dc20-S002.
ESC/EAS guidelines for the management of dyslipidaemias. Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. https://doi.org/10.1016/j.atherosclerosis.2019.08.014.
Korley FK, Datwyler SA, Jain S, Sun X, Beligere G, Chandran R, et al. Comparison of GFAP and UCH-L1 Measurements from two prototype assays: the Abbott i-STAT and ARCHITECT assays. Neurotrauma Rep. 2021;2:193–9. https://doi.org/10.1089/neur.2020.0037.
Brunkhorst R, Pfeilschifter W, Foerch C. Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Transl Stroke Res. 2010;1:246–51. https://doi.org/10.1007/s12975-010-0040-6.
Article CAS PubMed Google Scholar
Zhang S, Wu M, Peng C, Zhao G, Gu R. GFAP expression in injured astrocytes in rats. Exp Ther Med. 2017;14:1905–8. https://doi.org/10.3892/etm.2017.4760.
Article CAS PubMed PubMed Central Google Scholar
Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8: e62101. https://doi.org/10.1371/journal.pone.0062101.
Article CAS PubMed PubMed Central Google Scholar
Jouffroy R, Laney M, Leguillier T, Nivet-Antoine V, Beaudeux J-L. Comparaison des résultats de gaz du sang obtenus sur Abbott i-Stat et sur Radiometer ABL 800 Flex Impact sur la décision clinique. [Comparison of blood gas results obtained on Abbott i-Stat® and on Radiometer ABL 800 Flex® analyzers Impact for the clinical decision]. Ann Biol Clin (Paris). 2022;80:521–5. https://doi.org/10.1684/abc.2022.1765.
Schober P, Bossers SM, Koolwijk J, Terra M, Schwarte LA. Prehospital coagulation measurement by a portable blood analyzer in a helicopter emergency medical service (HEMS). Am J Emerg Med. 2021;46:137–40. https://doi.org/10.1016/j.ajem.2021.04.023.
Schober P, Bossers SM, Krage R, de Leeuw MA, Schwarte LA. Portable blood (Gas) analyzer in a helicopter emergency medical service. Air Med J. 2019;38:302–4. https://doi.org/10.1016/j.amj.2019.04.006.
Galvagno SM, Sikorski RA, Floccare DJ, Rock P, Mazzeffi MA, DuBose JJ, et al. Prehospital point of care testing for the early detection of shock and prediction of lifesaving interventions. Shock. 2020;54:710–6. https://doi.org/10.1097/SHK.0000000000001567.
Article CAS PubMed Google Scholar
Gilligan J, Reilly P, Pearce A, Taylor D. Management of acute traumatic intracranial haematoma in rural and remote areas of Australia. ANZ J Surg. 2017;87:80–5. https://doi.org/10.1111/ans.13583.
Paulino Campos MC, Venzel R, Pessoa de Oliveira L, Reis F, Oliveira de Amorim RL. Management of traumatic brain injury at a medium complexity hospital in a remote area of amazonas, 2017–2019. World Neurosurg. 2021;148:e151–4. https://doi.org/10.1016/j.wneu.2020.12.088.
Bischoff T, Briton J, Baumber B, Lewell M, Nolan B. A review of secondary interfacility trauma transfers meeting provincial prehospital trauma triage guidelines. CJEM. 2021;23:837–41. https://doi.org/10.1007/s43678-021-00192-x.
Otite FO, Akano EO, Akintoye E, Khandelwal P, Malik AM, Chaturvedi S, Rosand J. Rural-urban disparities in intracerebral hemorrhage mortality in the USA: preliminary findings from the national inpatient sample. Neurocrit Care. 2020;32:715–24. https://doi.org/10.1007/s12028-020-00950-2.
Sorensen MJ, von Recklinghausen FM, Fulton G, Burchard KW. Secondary overtriage: the burden of unnecessary interfacility transfers in a rural trauma system. JAMA Surg. 2013;148:763–8. https://doi.org/10.1001/jamasurg.2013.2132.
Qureshi AI, Huang W, Lobanova I, Barsan WG, Hanley DF, Hsu CY, et al. Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure: post hoc analysis of a randomized clinical trial. JAMA Neurol. 2020;77:1355–65. https://doi.org/10.1001/jamaneurol.2020.3075.
Kuramatsu JB, Sembill JA, Huttner HB. Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage. Crit Care. 2019.
留言 (0)